HYPAQUE-M LIQ 76% USP DIN 01904841
Health Canada record
| Active ingredient(s) | DIATRIZOATE MEGLUMINE 66 %; DIATRIZOATE SODIUM 10 % |
|---|---|
| Dosage form | Liquid |
| Route | Intravenous |
| Schedule | ETHICAL |
| Class | Human |
| ATC | V08AA01 DIATRIZOIC ACID |
| Original market date | 31-Dec-1992 |
| Current status date | 10-Sep-1996 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing DIATRIZOATE MEGLUMINE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02228564 | GASTROGRAFIN | BRACCO IMAGING CANADA | Solution | DIATRIZOATE MEGLUMINE 66 %; DIATRIZOATE SODIUM 10 % | Marketed |
| 01995669 | GASTROGRAFIN LIQ | SQUIBB DIAGNOSTICS, DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC. | Liquid | DIATRIZOATE MEGLUMINE 66 %; DIATRIZOATE SODIUM 10 % | Cancelled Post Market |
| 02180634 | HYPAQUE-M 18% | AMERSHAM HEALTH INC | Solution | DIATRIZOATE MEGLUMINE 18 % | Cancelled Post Market |
| 02026945 | HYPAQUE-M 18% LIQ | SANOFI CANADA, INC. | Liquid | DIATRIZOATE MEGLUMINE 18 % | Cancelled Post Market |
| 02180642 | HYPAQUE-M 30% | AMERSHAM HEALTH INC | Solution | DIATRIZOATE MEGLUMINE 30 % | Cancelled Post Market |
| 02026910 | HYPAQUE-M 30% LIQ | SANOFI CANADA, INC. | Liquid | DIATRIZOATE MEGLUMINE 30 % | Cancelled Post Market |
| 02180669 | HYPAQUE-M 60% | AMERSHAM HEALTH INC | Solution | DIATRIZOATE MEGLUMINE 60 % | Cancelled Post Market |
| 02026929 | HYPAQUE-M 60% LIQ | SANOFI CANADA, INC. | Liquid | DIATRIZOATE MEGLUMINE 60 % | Cancelled Post Market |
| 02026996 | HYPAQUE-M 76% LIQ | SANOFI CANADA, INC. | Liquid | DIATRIZOATE MEGLUMINE 66 %; DIATRIZOATE SODIUM 10 % | Cancelled Post Market |
| 00571024 | MD-60 | TYCO HEALTHCARE | Solution | DIATRIZOATE MEGLUMINE 520 MG; DIATRIZOATE SODIUM 80 MG | Cancelled Post Market |
| 00569739 | MD-76 | TYCO HEALTHCARE | Solution | DIATRIZOATE MEGLUMINE 660 MG; DIATRIZOATE SODIUM 100 MG | Cancelled Post Market |
| 02237155 | RENO-60 | BRACCO IMAGING CANADA | Liquid | DIATRIZOATE MEGLUMINE 600 MG | Cancelled Post Market |
| 02228572 | RENO-DIP | BRACCO IMAGING CANADA | Liquid | DIATRIZOATE MEGLUMINE 30 % | Cancelled Post Market |
| 00353841 | RENO-M-60 | SQUIBB CANADA INC., DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC. | Liquid | DIATRIZOATE MEGLUMINE 600 MG | Cancelled Post Market |
| 01973991 | RENO-M-DIP LIQ 30% | SQUIBB DIAGNOSTICS, DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC. | Liquid | DIATRIZOATE MEGLUMINE 30 % | Cancelled Post Market |
| 02232998 | RENOCAL-76 | BRACCO IMAGING CANADA | Liquid | DIATRIZOATE MEGLUMINE 66 %; DIATRIZOATE SODIUM 10 % | Cancelled Post Market |
| 02228580 | RENOGRAFIN-60 - LIQ IV | BRACCO IMAGING CANADA | Liquid | DIATRIZOATE MEGLUMINE 52 %; DIATRIZOATE SODIUM 8 % | Cancelled Post Market |
| 01974009 | RENOGRAFIN-60 LIQ | SQUIBB DIAGNOSTICS, DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC. | Liquid | DIATRIZOATE MEGLUMINE 52 %; DIATRIZOATE SODIUM 8 % | Cancelled Post Market |
| 02228637 | RENOGRAFIN-76 - LIQ IV | BRACCO IMAGING CANADA | Liquid | DIATRIZOATE MEGLUMINE 66 %; DIATRIZOATE SODIUM 10 % | Cancelled Post Market |
| 01963929 | RENOGRAFIN-76 LIQ | SQUIBB DIAGNOSTICS, DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC. | Liquid | DIATRIZOATE MEGLUMINE 66 %; DIATRIZOATE SODIUM 10 % | Cancelled Post Market |
| 00184330 | SINOGRAFIN | SQUIBB CANADA INC., DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC. | Liquid | DIATRIZOATE MEGLUMINE 52.7 %; MEGLUMINE IODIPAMIDE 26.9 % | Cancelled Post Market |
| 02228599 | SINOGRAFIN - LIQ IU | BRACCO IMAGING CANADA | Liquid | DIATRIZOATE MEGLUMINE 52.7 %; MEGLUMINE IODIPAMIDE 26.9 % | Cancelled Post Market |
International API supply for DIATRIZOATE MEGLUMINE
3 active FDA Drug Master Files.
Request a quote for HYPAQUE-M LIQ 76% USP